Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress

Download this slideset from our live meeting series to learn more about the optimal use of immune-oncology−based therapy for patients with RCC.
M. Dror Michaelson, MD, PhD
Robert Motzer, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.64 MB
Released: June 26, 2020

Acknowledgements

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC
NCCN Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by a medical education grant from Exelixis, Inc.

Supported by an independent educational grant from Merck & Co., Inc.

Supported by educational grants from
Eisai
Pfizer, Inc.

Related Content

Read expert advice about the importance of managing adjuvant abemaciclib adverse events in early breast cancer, from Clinical Care Options (CCO)

Julia LaBarbera, MSN, RN, AGACNP-BC Released: January 31, 2023

Dr Eric Jonasch discusses advances in the care of patients with renal cell carcinoma in this on-demand webcast from Clinical Care Options (CCO)

Naomi B. Haas, MD
Program Director
Eric Jonasch, MD
Program Director
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: January 26, 2023 Expired: January 25, 2024

In slides from Clinical Care Options (CCO), experts provide perspectives on updates in biomarker testing and targeted therapy across GI cancers

John L. Marshall, MD
Program Director
Christopher H. Lieu, MD Manish A. Shah, MD
Released: January 19, 2023

Downloadable slides on multidisciplinary approaches to managing high-risk, HR-positive/HER2-negative early breast cancer, from Clinical Care Options, (CCO)

Erika P. Hamilton, MD
Program Director
Joyce O'Shaughnessy, MD
Program Director
Released: January 4, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings